Literature DB >> 28791599

Comparison of NMR and Dynamic Light Scattering for Measuring Diffusion Coefficients of Formulated Insulin: Implications for Particle Size Distribution Measurements in Drug Products.

Sharadrao M Patil1, David A Keire2, Kang Chen3.   

Abstract

Particle size distribution, a measurable physicochemical quantity, is a critical quality attribute of drug products that needs to be controlled in drug manufacturing. The non-invasive methods of dynamic light scattering (DLS) and Diffusion Ordered SpectroscopY (DOSY) NMR can be used to measure diffusion coefficient and derive the corresponding hydrodynamic radius. However, little is known about their use and sensitivity as analytical tools for particle size measurement of formulated protein therapeutics. Here, DLS and DOSY-NMR methods are shown to be orthogonal and yield identical diffusion coefficient results for a homogenous monomeric protein standard, ribonuclease A. However, different diffusion coefficients were observed for five insulin drug products measured using the two methods. DOSY-NMR yielded an averaged diffusion coefficient among fast exchanging insulin oligomers, ranging between dimer and hexamer in size. By contrast, DLS showed several distinct species, including dimer, hexamer, dodecamer and other aggregates. The heterogeneity or polydisperse nature of insulin oligomers in formulation caused DOSY-NMR and DLS results to differ from each other. DLS measurements provided more quality attributes and higher sensitivity to larger aggregates than DOSY-NMR. Nevertheless, each method was sensitive to a different range of particle sizes and complemented each other. The application of both methods increases the assurance of complex drug quality in this similarity comparison.

Entities:  

Keywords:  diffusion; particle size distribution; physicochemical equivalence; protein drug product; similarity

Mesh:

Substances:

Year:  2017        PMID: 28791599      PMCID: PMC6058974          DOI: 10.1208/s12248-017-0127-z

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  26 in total

Review 1.  The FDA's assessment of follow-on protein products: a historical perspective.

Authors:  Janet Woodcock; Joseph Griffin; Rachel Behrman; Barry Cherney; Terrie Crescenzi; Blair Fraser; Dena Hixon; Christopher Joneckis; Steven Kozlowski; Amy Rosenberg; Lewis Schrager; Emily Shacter; Robert Temple; Keith Webber; Helen Winkle
Journal:  Nat Rev Drug Discov       Date:  2007-06       Impact factor: 84.694

2.  Solution structures of the R6 human insulin hexamer,.

Authors:  X Chang; A M Jorgensen; P Bardrum; J J Led
Journal:  Biochemistry       Date:  1997-08-05       Impact factor: 3.162

3.  Small amounts of sub-visible aggregates enhance the immunogenic potential of monoclonal antibody therapeutics.

Authors:  Maryam Ahmadi; Christine J Bryson; Edward A Cloake; Katie Welch; Vasco Filipe; Stefan Romeijn; Andrea Hawe; Wim Jiskoot; Matthew P Baker; Mark H Fogg
Journal:  Pharm Res       Date:  2015-04       Impact factor: 4.200

4.  Structure, Aggregation, and Activity of a Covalent Insulin Dimer Formed During Storage of Neutral Formulation of Human Insulin.

Authors:  Christian Fogt Hjorth; Mathias Norrman; Per-Olof Wahlund; Andrew J Benie; Bent O Petersen; Christian M Jessen; Thomas Å Pedersen; Kirsten Vestergaard; Dorte B Steensgaard; Jan Skov Pedersen; Helle Naver; František Hubálek; Christian Poulsen; Daniel Otzen
Journal:  J Pharm Sci       Date:  2016-02-23       Impact factor: 3.534

5.  Role of C-terminal B-chain residues in insulin assembly: the structure of hexameric LysB28ProB29-human insulin.

Authors:  E Ciszak; J M Beals; B H Frank; J C Baker; N D Carter; G D Smith
Journal:  Structure       Date:  1995-06-15       Impact factor: 5.006

6.  Effects of phenol and meta-cresol depletion on insulin analog stability at physiological temperature.

Authors:  Brandon M Teska; Javier Alarcón; Ronald J Pettis; Theodore W Randolph; John F Carpenter
Journal:  J Pharm Sci       Date:  2014-06-06       Impact factor: 3.534

7.  Diffusion of insulin-like growth factor-I and ribonuclease through fibrin gels.

Authors:  Jess V Nauman; Phil G Campbell; Frederick Lanni; John L Anderson
Journal:  Biophys J       Date:  2007-03-30       Impact factor: 4.033

8.  The lifetime of insulin hexamers.

Authors:  U Hassiepen; M Federwisch; T Mülders; A Wollmer
Journal:  Biophys J       Date:  1999-09       Impact factor: 4.033

9.  The application of DOSY NMR and molecular dynamics simulations to explore the mechanism(s) of micelle binding of antimicrobial peptides containing unnatural amino acids.

Authors:  Tiffany D Clark; Libero Bartolotti; Rickey P Hicks
Journal:  Biopolymers       Date:  2013-08       Impact factor: 2.505

10.  Direct insight into insulin aggregation by 2D NMR complemented by PFGSE NMR.

Authors:  Wojciech Bocian; Jerzy Sitkowski; Anna Tarnowska; Elzbieta Bednarek; Robert Kawecki; Wiktor Koźmiński; Lech Kozerski
Journal:  Proteins       Date:  2008-05-15
View more
  10 in total

1.  Evidence of oligomerization of bovine insulin in solution given by NMR.

Authors:  S V Efimov; Yu O Zgadzay; N B Tarasova; V V Klochkov
Journal:  Eur Biophys J       Date:  2018-06-01       Impact factor: 1.733

2.  Insight into human insulin aggregation revisited using NMR derived translational diffusion parameters.

Authors:  Jerzy Sitkowski; Wojciech Bocian; Elżbieta Bednarek; Mateusz Urbańczyk; Wiktor Koźmiński; Piotr Borowicz; Grażyna Płucienniczak; Natalia Łukasiewicz; Iwona Sokołowska; Lech Kozerski
Journal:  J Biomol NMR       Date:  2018-06-12       Impact factor: 2.835

3.  An ultrafast insulin formulation enabled by high-throughput screening of engineered polymeric excipients.

Authors:  Joseph L Mann; Caitlin L Maikawa; Anton A A Smith; Abigail K Grosskopf; Sam W Baker; Gillie A Roth; Catherine M Meis; Emily C Gale; Celine S Liong; Santiago Correa; Doreen Chan; Lyndsay M Stapleton; Anthony C Yu; Ben Muir; Shaun Howard; Almar Postma; Eric A Appel
Journal:  Sci Transl Med       Date:  2020-07-01       Impact factor: 17.956

4.  Chemometric Methods to Quantify 1D and 2D NMR Spectral Differences Among Similar Protein Therapeutics.

Authors:  Kang Chen; Junyong Park; Feng Li; Sharadrao M Patil; David A Keire
Journal:  AAPS PharmSciTech       Date:  2017-11-06       Impact factor: 3.246

5.  Stable Monomeric Insulin Formulations Enabled by Supramolecular PEGylation of Insulin Analogues.

Authors:  Caitlin L Maikawa; Anton A A Smith; Lei Zou; Catherine M Meis; Joseph L Mann; Matthew J Webber; Eric A Appel
Journal:  Adv Ther (Weinh)       Date:  2019-12-17

6.  A Simple and Noninvasive DOSY NMR Method for Droplet Size Measurement of Intact Oil-In-Water Emulsion Drug Products.

Authors:  Sharadrao M Patil; Vincent Li; Jiangnan Peng; Darby Kozak; Jin Xu; Bing Cai; David A Keire; Kang Chen
Journal:  J Pharm Sci       Date:  2018-10-03       Impact factor: 3.534

7.  Dynamic light scattering spectroscopy of the retina-a non-invasive quantitative technique to objectively document visual improvement following ocular stem cell treatment.

Authors:  Jeffrey N Weiss; Steven Levy
Journal:  Stem Cell Investig       Date:  2019-04-01

Review 8.  Analytical Similarity Assessment of Biosimilars: Global Regulatory Landscape, Recent Studies and Major Advancements in Orthogonal Platforms.

Authors:  Neh Nupur; Srishti Joshi; Davy Gulliarme; Anurag S Rathore
Journal:  Front Bioeng Biotechnol       Date:  2022-02-09

9.  Effects of silver nanoparticles coated with anti-HER2 on irradiation efficiency of SKBR3 breast cancer cells.

Authors:  Shahin Aghamiri; Ali Jafarpour; Mohsen Shoja
Journal:  IET Nanobiotechnol       Date:  2019-10       Impact factor: 1.847

10.  Small-Molecule-Based Self-Assembled Ligands for G-Quadruplex DNA Surface Recognition.

Authors:  María Del C Rivera-Sánchez; Marilyn García-Arriaga; Gerard Hobley; Ana V Morales-de-Echegaray; José M Rivera
Journal:  ACS Omega       Date:  2017-10-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.